CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

The FDA responded with a complete response letter (CRL) to the resubmitted biologics license application (BLA) for RP1 (vusolimogene oderparepvec), an oncolytic virus therapy, in combination with ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Researchers at Oregon Health & Science University have discovered that pancreatic cancer cells reshape their environment by ...

A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a ...

In recent years, CAR T-cell therapy has become a revolutionary, if risky, treatment for some late-stage cancers. Yet CAR T ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has reached a significant ...